PD-1 inhibitor + CCR5 inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PD-1 inhibitor + CCR5 inhibitor, covering 2021-04-22 to 2021-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Combined PD-1 and CCR5 Inhibition for the Treatment of Refractory Microsatellite Stable mCRC [Phase 1]